UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the Month of February 2025
CAMTEK LTD.
(Translation of Registrant’s Name into English)
Ramat Gavriel Industrial Zone
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal Corporate Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities and Exchange
Act of 1934.
Yes ☐ No ☒
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. This Form
6-K, including all exhibits hereto, is hereby incorporated by reference into all effective registration statements filed by the registrant under the Securities Act of 1933.
| |
|
CAMTEK LTD.
(Registrant)
By: /s/ Moshe Eisenberg
Moshe Eisenberg,
Chief Financial Officer
|
Dated: February 12, 2025
|
|
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park
Migdal Ha’Emek 23150, ISRAEL
Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523
E-Mail: Info@camtek.com Web site: http://www.camtek.com
|
|
CAMTEK LTD.
Moshe Eisenberg, CFO
Tel: +972 4 604 8308
Mobile: +972 54 900 7100
moshee@camtek.com
|
INTERNATIONAL INVESTOR RELATIONS
EK Global Investor Relations
Ehud Helft
Tel: (US) 1 212 378 8040
camtek@ekgir.com
|
FOR IMMEDIATE RELEASE
CAMTEK ANNOUNCES RECORD RESULTS FOR THE
FOURTH QUARTER & FULL YEAR OF 2024
Q4 revenues of $117 million; Q1 2025 revenue guidance of $118-120 million, up ~23% YoY
MIGDAL HAEMEK, Israel – February 12, 2025 – Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced its financial results for the fourth quarter and year ended December 31, 2024.
2024 Fourth Quarter Financial Highlights
|
• |
Record revenues of $117.3 million, a 32% YoY increase;
|
|
• |
GAAP operating income of $31.3 million (up 82% YoY) and non-GAAP operating income of $36.3 million (up 42% YoY), representing operating margins of 26.7% and 30.9%, respectively; and
|
|
• |
GAAP net income of $33.0 million (up 59% YoY) and non-GAAP net income of $37.7 million (up 34% YoY); GAAP diluted EPS of $0.67 and non-GAAP diluted EPS of $0.77.
|
2024 Full-Year Financial Highlights
|
• |
Record revenues of $429.2 million, a 36% YoY increase.
|
|
• |
GAAP operating income of $108.1 million (up 65% YoY); non-GAAP operating income of $130.3 million (up 56% YoY), representing operating margins of 25.2% and 30.4%, respectively;
|
|
• |
GAAP net income of $118.5 million (up 51% YoY); non-GAAP net income of $138.6 million (up 45% YoY); GAAP diluted EPS of $2.42 and non-GAAP diluted EPS of $2.83; and
|
|
• |
Operating cash flow of $122.2 million in 2024, which led to a year-end total cash, short-term and long-term deposits and marketable securities balance of $501.2 million.
|
Forward-Looking Expectations
Management expects continued growth in 2025 with revenues in the first quarter of 2025 in the range of $118-120 million, representing approximately a 23% increase over first quarter of 2024 revenues.
Management Comment
Rafi Amit, Camtek’s CEO commented, “2024 was a year of a strong growth in revenue and even higher growth in profit. Looking ahead, Camtek ended 2024 with a
record quarter and a strong backlog which indicates continued growth into 2025. As we enter 2025, we are excited to launch the technologically innovative Eagle G5 and Hawk systems that broaden our portfolio, enhance our competitiveness, and enable us
to enter new markets.”
Continued Mr. Amit, “The growing demand for AI has positioned Camtek as a leader and facilitated our significant growth in 2024. We believe we will continue to
capitalize on the increasing need for AI applications, which necessitate considerable investments in high-performance computing (HPC) hardware. We will further benefit as AI becomes integrated into mainstream devices like automobiles, robotics, PCs,
and mobile phones.”
Fourth Quarter 2024 Financial Results
Revenues for the fourth quarter of 2024 were $117.3 million. This compares to fourth quarter 2023 revenues of $88.7 million, representing a year-over-year
growth of 32%.
Gross profit on a GAAP basis in the quarter totaled $58.1 million (49.6% of revenues), an increase of 46% compared to a gross profit of $39.8 million (44.9% of
revenues) in the fourth quarter of 2023.
Gross profit on a non-GAAP basis in the quarter totaled $59.3 million (50.6% of revenues), an increase of 36% compared to a gross profit of $43.7 million
(49.2% of revenues) in the fourth quarter of 2023.
Operating income on a GAAP basis in the quarter totaled $31.3 million (26.7% of revenues), an increase of 82% compared to an operating income of $17.2 million
(19.4% of revenues) in the fourth quarter of 2023.
Operating income on a non-GAAP basis in the quarter totaled $36.3 million (30.9% of revenues), an increase of 42% compared to $25.5 million (28.7% of revenues)
in the fourth quarter of 2023.
Net income on a GAAP basis in the quarter totaled $33.0 million, or $0.67 per diluted share, an increase of 59% compared to net income of $20.8 million, or
$0.42 per diluted share, in the fourth quarter of 2023.
Net income on a non-GAAP basis in the quarter totaled $37.7 million, or $0.77 per diluted share, an increase of 34% compared to a non-GAAP net income of $28.2
million, or $0.57 per diluted share, in the fourth quarter of 2023.
Full Year 2024 Results Summary
Revenues for 2024 were $429.2 million, a 36% increase compared to the $315.4 million as reported in 2023.
Gross profit on a GAAP basis totaled $209.9 million (48.9% of revenues), a 42% increase compared to $147.6 million (46.8% of revenues) in 2023.
Gross profit on a non-GAAP basis totaled $218.0 million (50.8% of revenues), a 43% increase compared to $152.7 million (48.4% of revenues) in 2023.
Operating income on a GAAP basis totaled $108.1 million (25.2% of revenues), a 65% increase compared to operating income of $65.4 million (20.7% of revenues)
in 2023.
Operating income on a non-GAAP basis totaled $130.3 million (30.4% of revenues), a 56% increase compared to $83.3 million (26.4% of revenues) in 2023.
Net income on a GAAP basis totaled $118.5 million, or $2.42 per diluted share. This is an increase of 51% compared to net income of $78.6 million, or $1.61
per diluted share, in 2023.
Net income on a non-GAAP basis totaled $138.6 million, or $2.83 per diluted share. This is an increase of 45% compared
to net income of $95.7 million, or $1.96 per diluted share, in 2023.
Cash and cash equivalents, short-term and long-term deposits, and marketable securities, as of December 31, 2024, were $501.2 million compared to $448.6 million as of December 31,
2023, and $488.7 million as of September 30, 2024. During the fourth quarter, the Company generated an operating cash flow of $16.2 million.
Conference Call
Camtek will host a video conference call/webinar today via Zoom, on Wednesday, February 12, 2025, at 09:00 ET (16:00 Israel time). Rafi Amit, CEO, Moshe Eisenberg, CFO, and Ramy Langer, COO will host
the call and will be available to answer questions after presenting the results.
To participate in the webinar, please register using the following link, which will provide access to the video call: https://us06web.zoom.us/webinar/register/WN_9cx6Ew0UQsucYsHDA_qMow
For those wishing to listen via phone, following registration, the dial in link will be sent. For any problems in registering, please email Camtek’s investor relations a few hours in advance of the
call.
For those unable to participate, a recording will be available on Camtek’s website at http://www.camtek.com within a few hours after the call.
A summary presentation of the quarterly results will also be available on Camtek’s website.
ABOUT CAMTEK LTD.
Camtek is a developer and manufacturer of high-end inspection and metrology equipment for the semiconductor industry. Camtek's systems inspect IC and measure IC features on wafers throughout the
production process of semiconductor devices, covering the front and mid-end and up to the beginning of assembly (Post Dicing). Camtek's systems inspect wafers for the most demanding semiconductor market segments, including Advanced Interconnect
Packaging, Heterogenous Integration, Memory and HBM, CMOS Image Sensors, Compound Semiconductors, MEMS, and RF, serving numerous industry's leading global IDMs, OSATs, and foundries.
With manufacturing facilities in Israel and Germany, and eight offices around the world, Camtek provides state of the art solutions in line with customers' requirements.
This press release is available at http://www.camtek.com
This press release contains statements that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements are based on Camtek’s current beliefs, expectations and assumptions about its business and industry, all of which may change. Forward-looking statements can be identified by the use of words including “believe,”
“anticipate,” “should,” “intend,” “plan,” “will,” “may,” “expect,” “estimate,” “project,” “positioned,” “strategy,” and similar expressions that are intended to identify forward-looking statements, including statements relating to the compound
semiconductors market and our position in this market and the anticipated timing of delivery of the systems. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or
achievements of Camtek to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause our actual results to differ materially from those contained in the
forward-looking statements include, but are not limited to the effects of the evolving nature of the war situation in Israel, and the related evolving regional conflicts; the continued demand for HPC, HBM and Chiplet devices resulting from, among
other things, the field of AI surging worldwide across companies, industries and nations; our dependency upon the semiconductor industry and the risk that unfavorable economic conditions or low capital expenditures may negatively impact our operating
results; risks related to the Company's ability to effectively maneuver global trade issues and changes either in the U.S., Israel, or elsewhere in trade and export regulations, tariffs, and license policies, including formal or informal imposition
by countries of new or revised export and/or import and doing-business regulations or sanctions, and further including changes in U.S. trade policies, changes or uncertainty related to the U.S. government entity list and changes in the ability to
sell products incorporating U.S originated technology, which can be made without prior notice; the risks relating to the concentration of a significant portion of our business in certain countries in the Asia Pacific Region, particularly China,
Taiwan and Korea, some of which might be subject to the trade restrictions referred to above or involved in trade wars with countries which might impose such trade restrictions; changing industry and market trends; and those other factors discussed
in our Annual Report on Form 20-F as published on March 21, 2024, as well as other documents that may be subsequently filed by Camtek from time to time with the Securities and Exchange Commission. We caution you not to place undue reliance on
forward-looking statements, which speak only as of the date hereof. Camtek does not assume any obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release unless
required by law.
While we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a
combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. In addition, any forward-looking statements represent Camtek’s views only as of the date of this press release and should not
be relied upon as representing its views as of any subsequent date. Camtek does not assume any obligation to update any forward-looking statements unless required by law.
This press release provides financial measures that exclude: (i) share based compensation expenses; and (ii) acquisition related expenses and are therefore not calculated in
accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance. The presentation of this non-GAAP financial information
is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt
it is important to make these non-GAAP adjustments available to investors. A reconciliation between the GAAP and non-GAAP results appears in the tables at the end of this press release. The results reported in this press-release are preliminary
unaudited results, and investors should be aware of possible discrepancies between these results and the audited results to be reported, due to various factors.
CAMTEK LTD. and its subsidiaries
Consolidated Balance Sheets
(In thousands)
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
Assets
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
126,224
|
|
|
|
119,968
|
|
|
Short-term deposits
|
|
|
231,000
|
|
|
|
215,250
|
|
|
Marketable securities
|
|
|
30,813
|
|
|
|
18,816
|
|
|
Trade accounts receivable, net
|
|
|
99,471
|
|
|
|
87,300
|
|
|
Inventories
|
|
|
111,204
|
|
|
|
85,905
|
|
|
Other current assets
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Long-term deposits
|
|
|
26,000
|
|
|
|
21,000
|
|
|
Marketable securities
|
|
|
87,115
|
|
|
|
73,576
|
|
|
Long-term inventory
|
|
|
11,879
|
|
|
|
9,023
|
|
|
Deferred tax asset, net
|
|
|
3,090
|
|
|
|
2,642
|
|
|
Other assets, net
|
|
|
2,001
|
|
|
|
1,370
|
|
|
Property, plant and equipment, net
|
|
|
54,196
|
|
|
|
41,987
|
|
|
Intangible assets, net
|
|
|
13,357
|
|
|
|
16,937
|
|
|
Goodwill
|
|
|
|
|
|
|
|
|
|
Total non- current assets
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Liabilities and shareholders’ equity
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
Trade accounts payable
|
|
|
46,630
|
|
|
|
42,187
|
|
|
Other current liabilities
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
123,910
|
|
|
|
96,674
|
|
| |
|
|
|
|
|
|
|
|
|
Long-term liabilities
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities, net
|
|
|
5,606
|
|
|
|
7,541
|
|
|
Other long-term liabilities
|
|
|
15,366
|
|
|
|
10,473
|
|
|
Convertible notes
|
|
|
|
|
|
|
|
|
|
Total long-term liabilities
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Shareholders’ equity
|
|
|
|
|
|
|
|
|
|
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at December 31, 2024 and at December 31, 2023;
|
|
|
|
|
|
|
|
|
|
47,541,682 issued shares at December 31, 2024 and 46,993,998 at December 31, 2023;
|
|
|
|
|
|
|
|
|
|
45,449,306 shares outstanding at December 31, 2024 and 44,901,622 at December 31, 2023
|
|
|
177
|
|
|
|
176
|
|
|
Additional paid-in capital
|
|
|
214,931
|
|
|
|
200,389
|
|
|
Accumulated other comprehensive income
|
|
|
203
|
|
|
|
129
|
|
|
Retained earnings
|
|
|
|
|
|
|
|
|
| |
|
|
551,133
|
|
|
|
478,046
|
|
|
Treasury stock, at cost (2,092,376 as of December 31, 2024 and December 31, 2023)
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total shareholders' equity
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity
|
|
|
|
|
|
|
|
|
Consolidated Statements of Income
(in thousands, except share data)
| |
|
|
|
|
Three Months ended December 31,
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
Revenues
|
|
|
429,234
|
|
|
|
315,375
|
|
|
|
117,293
|
|
|
|
88,690
|
|
|
Cost of revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development costs
|
|
|
38,287
|
|
|
|
31,470
|
|
|
|
10,371
|
|
|
|
8,042
|
|
|
Selling, general and administrative expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
101,882
|
|
|
|
82,221
|
|
|
|
26,832
|
|
|
|
22,569
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial income, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per ordinary share:
| |
|
|
|
|
Three Months ended December 31,
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net earnings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net earnings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ordinary shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP To Non-GAAP results
(In thousands, except share data)
|
|
|
|
|
Three Months ended December 31,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income attributable to Camtek Ltd. on GAAP basis
|
|
|
118,515
|
|
|
|
78,632
|
|
|
|
33,009
|
|
|
|
20,790
|
|
|
Acquisition of FRT related expenses (1)
|
|
|
5,334
|
|
|
|
4,550
|
|
|
|
650
|
|
|
|
4,550
|
|
|
Share-based compensation
|
|
|
14,775
|
|
|
|
12,525
|
|
|
|
4,052
|
|
|
|
2,868
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non–GAAP net income per diluted share
|
|
|
2.83
|
|
|
|
1.96
|
|
|
|
0.77
|
|
|
|
0.57
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin on GAAP basis
|
|
|
49.6
|
%
|
|
|
46.8
|
%
|
|
|
50.6
|
%
|
|
|
44.9
|
%
|
|
Reported gross profit on GAAP basis
|
|
|
209,951
|
|
|
|
147,633
|
|
|
|
58,132
|
|
|
|
39,788
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition of FRT-related expenses (1)
|
|
|
5,802
|
|
|
|
3,492
|
|
|
|
610
|
|
|
|
3,492
|
|
|
Share-based compensation
|
|
|
2,197
|
|
|
|
1,591
|
|
|
|
595
|
|
|
|
395
|
|
|
Non-GAAP gross margin
|
|
|
50.8
|
%
|
|
|
48.4
|
%
|
|
|
50.6
|
%
|
|
|
49.2
|
%
|
|
Non-GAAP gross profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported operating income (loss) attributable to Camtek Ltd. on GAAP basis
|
|
|
108,069
|
|
|
|
65,412
|
|
|
|
31,300
|
|
|
|
17,219
|
|
|
Acquisition of FRT-related expenses (1)
|
|
|
7,455
|
|
|
|
5,406
|
|
|
|
928
|
|
|
|
5,406
|
|
|
Share-based compensation
|
|
|
14,775
|
|
|
|
12,525
|
|
|
|
4,052
|
|
|
|
2,868
|
|
|
Non-GAAP operating income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) During the year ended December 31, 2024, the Company recorded acquisition-related expenses of $5.3 million, consisting of: (1) inventory written-up to fair value in purchase accounting charges of $3.4 million. This
amount is recorded under cost of revenues line item. (2) $2.4 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) $1.3 million amortization of intangible assets acquired recorded under sales and
marketing expenses line item. (4) $0.4 million re-organization expenses, recorded under the general and administrative expenses line item. (5) $2.1 million reversal of tax provision related to the above adjustment, recorded under the tax expense
line item.
During the three-month period ended December 31, 2024, the Company recorded acquisition-related expenses of $0.6 million, consisting of: (1) $0.6 million amortization of intangible assets acquired recorded under cost
of revenues line item. (2) $0.3 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (3) $0.3 million reversal of tax provision related to the above adjustment, recorded under the tax expense
line item.
During the year and three-month period ended December 31, 2023, the Company recorded acquisition expenses of $4.5 million, consisting of: (1) inventory written-up to fair value in purchase
accounting charges of $2.2 million. This amount was recorded under cost of revenues line item. (2) $0.4 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) Inventory write-off of $0.9 million recorded
under costs of revenues line item. (4) $0.2 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (5) Acquisition expenses of $1.7 million recorded under general and administrative expenses line
item. (6) $0.9 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.
